Publication | Open Access

Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors

Pulmonary TuberculosisHealth SciencesMedicineAntibiotic AdjuvantMycobacterium TuberculosisTuberculosisCapuramycin AnalogCombination TherapyMicrobiologySynergistic EffectsPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance